Read More Healthcare Industry News Boston Scientific to acquire Penumbra for $14.5bn in transformative vascular and neurovascular expansion move Boston Scientific’s $14.5B acquisition of Penumbra signals an aggressive move into neurovascular and thrombectomy markets. Find out what this means for medtech. bySrinathJanuary 21, 2026